<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>49</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>80(24)</volume><submitter>Mendoza JA</submitter><pubmed_abstract>Mechanisms of cellular transformation associated with human papillomavirus type 5 (HPV5), which is responsible for skin carcinomas in epidermodysplasia verruciformis (EV) patients, are poorly understood. Using a yeast two-hybrid screening and molecular and cellular biology experiments, we found that HPV5 oncoprotein E6 interacts with SMAD3, a key component in the transforming growth factor beta1 (TGF-beta1) signaling pathway. HPV5 E6 inhibits SMAD3 transactivation by destabilizing the SMAD3/SMAD4 complex and inducing the degradation of both proteins. Interestingly, the E6 protein of nononcogenic EV HPV9 failed to interact with SMAD3, suggesting that downregulation of the TGF-beta1 signaling pathway could be a determinant in HPV5 skin carcinogenesis.</pubmed_abstract><journal>Journal of virology</journal><pagination>12420-4</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1676262</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.</pubmed_title><pmcid>PMC1676262</pmcid><pubmed_authors>Jacob Y</pubmed_authors><pubmed_authors>Favre M</pubmed_authors><pubmed_authors>Cassonnet P</pubmed_authors><pubmed_authors>Mendoza JA</pubmed_authors><view_count>49</view_count></additional><is_claimable>false</is_claimable><name>Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.</name><description>Mechanisms of cellular transformation associated with human papillomavirus type 5 (HPV5), which is responsible for skin carcinomas in epidermodysplasia verruciformis (EV) patients, are poorly understood. Using a yeast two-hybrid screening and molecular and cellular biology experiments, we found that HPV5 oncoprotein E6 interacts with SMAD3, a key component in the transforming growth factor beta1 (TGF-beta1) signaling pathway. HPV5 E6 inhibits SMAD3 transactivation by destabilizing the SMAD3/SMAD4 complex and inducing the degradation of both proteins. Interestingly, the E6 protein of nononcogenic EV HPV9 failed to interact with SMAD3, suggesting that downregulation of the TGF-beta1 signaling pathway could be a determinant in HPV5 skin carcinogenesis.</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 Dec</publication><modification>2024-10-15T05:04:01.133Z</modification><creation>2019-06-06T12:46:22Z</creation></dates><accession>S-EPMC1676262</accession><cross_references><pubmed>17020941</pubmed><doi>10.1128/JVI.02576-05</doi><doi>10.1128/jvi.02576-05</doi></cross_references></HashMap>